Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACCEL® Absorbable Hemostat Powder Clinical Trial

NCT04728087 is registered in ClinicalTrials.gov with Hemostasis, LLC as lead sponsor.

NCT NCT04728087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACCEL® Absorbable Hemostat Powder Clinical Trial
Lead sponsor
Hemostasis, LLC
Phase
Not applicable
Overall status
Unknown status
Start date
October 26, 2021
Completion date
January 30, 2025
Enrollment
216 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis